FUSION PROTEINS AND METHODS THEREOF

MODIFIED FILAMINS AND THEIR USES

BIO PROTAC PROTEIN HAVING INTRACELLULAR DELIVERY FUNCTION, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

ENGINEERED BIOMOLECULES FOR NUTRIENT REPROGRAMMING

EPITOPE-SCAFFOLD IMMUNOGENS FOR PANCORONAVIRUS VACCINES

Stabilized influenza hemagglutinin stem region trimers and uses thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS

CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES

Therapeutic Editing

TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF

MULTISPECIFIC PROTEINS

NUCLEIC ACID MOLECULES

Methods and compositions for protein sequencing

EPITOPE PEPTIDE OF HUMAN ALPHA-SYNUCLEIN AND PHARMACEUTICAL COMPOSITION INCLUDING SAID PEPTIDE

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS

ANTI-PD-1×4-1BB BINDING PROTEINS

NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES

COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN

MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY

RECOMBINANT HOSTS COMPRISING FERRITIN OR HOMOLOGUES THEREOF

FUSION PROTEINS AND METHODS THEREOF

NOVEL PROTEIN SPECIFICALLY BINDING TO CALRETICULIN AND HAVING HUMAN FIBRONECTIN DOMAIN III SCAFFOLD AND USE THEREOF

N-Terminal Capping Modules of Ankyrin Repeat Domains

HYPERSIALYLATING CELLS

VARIANT OF A BPIFB4 PROTEIN

POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS

VIRAL VECTOR-BASED GENE THERAPY FOR OCULAR CONDITIONS

A CONJUGATE, COMPOSITION AND METHOD FOR NONCOVALENT ANTIBODY CATENATION THAT INCREASES ANTIGEN-BINDING AVIDITY OF AN ANTIBODY IN PROPORTION TO THE DENSITY OF A TARGET ANTIGEN

COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS

ALPHA SYNUCLEIN SUBSTRATES AND METHODS FOR MAKING AND USING THE SAME

REDOX SENSITIVE CRALBP MUTANT PROTEINS

PEPTIDES AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

Molecules for organelle-specific protein delivery

NOVEL CANINE ODORANT BINDING PROTEINS

RNA Containing Modified Nucleosides and Methods of Use Thereof

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

MUTATED FERRITIN PROTEIN

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS

MYELOID-SPECIFIC PROMOTER AND USE THEREOF

PH20 polypeptide variants, formulations and uses thereof

PHI29 POLYMERASE FUSION PROTEINS AND USES THEREOF

NOVEL PROTEIN HAVING METHANE OR BUTANE OXIDATION ACTIVITY

ENGINEERED Fc CONSTRUCTS

G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)

Compositions and method of use for hair straightening and shaping

CHACTERIZATION OF BIOLOGICAL ACTIVITY OF FERRITIN PROTEIN BY MASS PRODUCTION USING THE RECOMBINANT VECTOR

THERAPEUTIC COMPOSITIONS COMPRISING MICROBE-TARGETING MOLECULES AND THEIR USE IN METHODS OF PREVENTING AND TREATING INFECTIOUS DISEASE

Genetically encoded system for constructing and detecting biologically active agents

SIGNAL PEPTIDES

RECOMBINANT AAVS FOR DELIVERY TO CENTRAL NERVOUS SYSTEM AND BRAIN VASCULATURE

RECOMBINANT PROTEIN CAPABLE OF RESISTING MULTIPLE SCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

HIDDEN ANTIBIOTICS IN THE HUMAN PROTEOME

COMPOSITIONS AND METHODS OF TREATING USHER SYNDROME III

Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules

MICROPEPTIDES AND USES THEREOF

SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION

ATF5 peptide variants and uses thereof

MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION

METHODS AND MATERIALS FOR TREATING PROPIONIC ACIDEMIA

ENGINEERING PROBIOTIC FOR DEGRADING URIC ACID, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN

ENHANCING T CELL FUNCTION THROUGH THE USE OF PROXIMAL SIGNALING MOLECULES

METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS

Fc fusion molecules and uses thereof

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

NON-TRANSGENE TRANSFECTION FOR THERAPEUTIC PURPOSES

ANTIBODY PRODUCING NON-HUMAN ANIMALS

GENE THERAPY FOR DENT DISEASE

METHOD FOR PRODUCING HYPOIMMUNOGENIC RETINAL PIGMENT EPITHELIAL CELLS

MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENIFYING AGENTS THAT MODULATE MYC

METHODS TO GENETICALLY ENGINEER HEMATOPOIETIC STEM AND PROGENITOR CELLS FOR RED CELL SPECIFIC EXPRESSION OF THERAPEUTIC PROTEINS

ANTIBODY PRODUCING NON-HUMAN ANIMALS

LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS

IMMUNOGENIC PROTEIN HYDROLYSATE WITH REDUCED ALLERGENICITY

DISEASE ANTIGEN-FUSED PROTEIN, AND USE THEREOF

PROTEIN FUSED WITH MOLECULE CAPABLE OF BINDING TO IMMUNE CHECKPOINT MOLECULE AND USE OF SAME

RODENTS HAVING A HUMANIZED TMPRSS GENE

USE OF MESENCHYMAL STEM CELLS OVEREXPRESSING PACER FOR THE TREATMENT OF DISEASES WITH INFLAMMATORY ORIGIN AND/OR COMPONENT

Activin receptor type IIB variants and methods of use thereof

MUTATED ANNEXIN A5 POLYPEPTIDES AND USES THEREOF FOR THERAPEUTIC PURPOSES

ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

VIRAL VECTOR-BASED GENE THERAPY FOR OCULAR CONDITIONS

A CONJUGATE, COMPOSITION AND METHOD FOR NONCOVALENT ANTIBODY CATENATION THAT INCREASES ANTIGEN-BINDING AVIDITY OF AN ANTIBODY IN PROPORTION TO THE DENSITY OF A TARGET ANTIGEN

PEPTIDES AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

NOVEL CANINE ODORANT BINDING PROTEINS

RNA Containing Modified Nucleosides and Methods of Use Thereof

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

DESIGNED ANKYRIN REPEAT DOMAIN WITH IMPROVED STABILITY

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS

SOYBEAN ALLERGY ANTIGEN

TARGET FOR SCREENING ANTI-TUMOR DRUG, USE THEREOF AND SCREENING METHOD THEREFOR

COMPOSITIONS FOR TREATMENT OF CONDITIONS AND DISEASES ASSOCIATED WITH POLYCYSTIN EXPRESSION

USE OF MIRNA-485 INHIBITOR TO REGULATE PSD95, SYNAPTOPHYSIN, AND CASPASE-3 EXPRESSION

FUSION PROTEIN, FUSION PROTEIN PRODUCTION METHOD, ELECTRODE, REDOX DEVICE, REDOX METHOD, DISULFIDE BOND CLEAVAGE METHOD, AND ALLERGEN INACTIVATION METHOD

DNA NUCLEASE GUIDED TRANSPOSASE COMPOSITIONS AND METHODS OF USE THEREOF

REAGENTS FOR DETECTION OF N-GLYCOSYLATION

FISH ALLERGY ANTIGEN

COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER

Bi-Specific Fusion Proteins

EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE

MOLECULAR SUPERSTRUCTURE AND METHODS OF USE THEREOF

GLYCAN-BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL BY USING CRISPR/CAS SYSTEM

Compositions and methods for treating non-age-associated hearing impairment in a human subject

IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH

METHODS FOR EXPANDING IMMUNE CELLS

INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS

MINIMAL BILE ACID INDUCIBLE PROMOTERS FOR GENE THERAPY

GENETIC ENGINEERING OF MACROPHAGES FOR IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL

Cancer Vaccines and Methods of Treatment Using The Same

MINIGENE THERAPY

cGMP exosome loaded therapeutics for treating sickle cell disease

ENGINEERED EXOSOMES TO DETECT AND DEPLETE PRO-TUMORIGENIC MACROPHAGES

COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS

TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES

Compositions and methods for treatment of chronic lung diseases

Methods and Compositions for Targeting Polyubiquitin

T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR

METHODS AND COMPOSITIONS FOR TREATMENT OF FRIEDREICH'S ATAXIA

USE OF PSILOCYBIN IN CANCER TREATMENT

EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK

RECOMBINANT CD3 BINDING PROTEINS AND THEIR USE

Vesicle Targeting Proteins And Uses Of Same

N-Terminal Capping Modules of Ankyrin Repeat Domains

ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS

Optimized expression cassettes for gene therapy

CYTOSINE TO GUANINE BASE EDITOR

DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF

USE OF REGULATOR OF ITPRIPL1 IN PREPARATION OF DRUG THAT REGULATES IMMUNE RESPONSES OR FIGHTS TUMORS

FUSION PROTEINS COMPRISING MILK PROTEINS AND COMPOSITIONS THEREOF

IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

METHOD FOR PURIFICATION OF HEMOPEXIN AND HAPTOGLOBIN

Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

ARTIFICIALLY SYNTHESIZED mRNA AND USE OF SAME

Compositions and Methods for the Treatment of Alzheimer's Disease

COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION

METHODS AND COMPOSITIONS FOR TREATING TECPR2-ASSOCIATED DISEASE AND DISORDERS WITH A VIRAL VECTOR

ANTIBODY PRODUCING NON-HUMAN ANIMALS

Exosome-targeted DNA vaccine

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF

DUAL-AAV VECTOR DELIVERY OF PCDH15 AND USES THEREOF

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER

Compositions and methods for treating non-age-associated hearing impairment in a human subject

PH20 polypeptide variants, formulations and uses thereof

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 polypeptide variants, formulations and uses thereof

FRATAXIN EXPRESSION CONSTRUCTS

ADP-RIBOSE BINDING PEPTIDES WITH ANTI-CANCER ACTIVITY AND USE THEREOF

PRION-FC REGION FUSION PROTEIN AND USE THEREOF

GENE KNOCK-OUT FOR TREATMENT OF GLAUCOMA

NEOANTIGENS AND METHODS OF THEIR USE

MUTANT NGAL PROTEINS AND USES THEREOF

Allograft tolerance without the need for systemic immune suppression

Compositions and methods for treating non-age-associated hearing impairment in a human subject

ENGINEERED CELLULAR ADHESION MOLECULES AND METHODS OF USE THEREOF

NEOANTIGENS AND METHODS OF THEIR USE

CARRIER PEPTIDE FRAGMENT AND USE THEREOF

FUSION PROTEIN AND USE THEREOF

VARIANT TXNIP COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES

ANTIBODY-LIKE PROTEIN AND USE THEREOF

WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES TARGETING CORONAVIRUSES

BACTERIA BASED PROTEIN DELIVERY

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

PEPTIDE INHIBITORS OF GLIOMA-ASSOCIATED ONCOGENE DERIVED FROM THE COILED-COIL DIMERIZATION DOMAIN OF Kif7

METHOD TO IMPROVE PROTEIN QUALITY CONTROL

PHARMACEUTICAL COMBINATION AND USE THEREOF

COMPOSITION AND METHODS FOR MODULATING TCF4 GENE EXPESSION AND TREATING PITT HOPKINS SYNDROME

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

BIOORTHOGONAL REPORTER GENE SYSTEM

PH20 polypeptide variants, formulations and uses thereof

VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION

Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

INDUCIBLE CASPASES AND METHODS FOR USE

Peptides

DESIGNED ANKYRIN REPEAT DOMAINS WITH ALTERED SURFACE RESIDUES

NPY2 receptor agonists

RECOMBINANT ADENO ASSOCIATED VIRUS (RAAV) ENCODING GJB2 AND USES THEREOF

INHIBITORS OF ?-SYNUCLEIN AGGREGATION AND USES THEREOF

NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES

SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

MIRAC PROTEINS

PEPTIDE FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

MATERIALS AND METHODS FOR TREATMENT OF FRIEDREICH ATAXIA AND OTHER RELATED DISORDERS

GENE THERAPY FOR LIPODYSTROPHY

GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF

EPCAM BINDING FIBRONECTIN TYPE III DOMAINS

Stabilized influenza hemagglutinin stem region trimers and uses thereof

VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

Bi-Specific Fusion Proteins

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

SYSTEMS AND METHODS FOR CONTROL OF GENE EXPRESSION

ANKYRIN-RICH BTB/POZ DOMAIN-CONTAINING PROTEIN-2 (ABTB2) FOR SUPPRESSING PANCREATIC CANCER GROWTH

FUSION PROTEINS AND METHODS THEREOF

Compositions and methods for targeted delivery to cells

TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS

METHOD OF IMPROVING ACID DECARBOXYLASE ACTIVITY IN VITRO UNDER ALKALINE PH

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

Chimeric inhibitor molecules of complement activation

ALLERGY ANTIGEN AND EPITOPE FOR SAME

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

Compositions and methods for increasing plant growth and improving multiple yield-related traits

GENE THERAPIES FOR LYSOSOMAL DISORDERS

HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS)

OPTIMIZED SLC13A5 GENES AND EXPRESSION CASSETTES AND THEIR USE

METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES

Targeting anabolic drugs for accelerated fracture repair

MODIFIED FERRITIN AND METHOD FOR PRODUCING THE SAME

COMPOSITIONS CONTAINING HC-HA/PTX3 COMPLEXES AND METHODS OF USE THEREOF

Methods and systems for solid phase peptide synthesis

A NOVEL MUSCLE-SPECIFIC PROMOTER

GENETICALLY ENCODED YEATS DOMAIN PROBE AND APPLICATIONS THEREOF

CCN3 and CCN3 peptides and analogs thereof for therapeutic use

MODIFIED SEMAPHORIN 3A, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF

Compositions Useful in Treatment of Spinal Muscular Atrophy

IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES

GENE THERAPY FOR STXBP1 ENCEPHALOPATHY

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PROGRANULIN VARIANTS

USE OF CNPY3 PROTEIN AS TARGET FOR TREATING OF DENGUE FEVER

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

CH1 DOMAIN VARIANTS ENGINEERED FOR PREFERENTIAL LIGHT CHAIN PAIRING AND MULTISPECIFIC ANTIBODIES COMPRISING THE SAME

PEPTIDE ADJUVANT FOR ITS THERAPEUTIC APPLICATIONS IN VIRAL AND TUMOUR VACCINE DEVELOPMENT AND CANCER IMMUNOTHERAPY AND AUTOIMMUNE DISEASE DIAGNOSIS AND TREATMENTS

COMPOSITIONS, METHODS AND USES COMPRISING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE -1 (TCAP-1) FOR ENHANCING MUSCLE PERFORMANCE

PH20 polypeptide variants, formulations and uses thereof

NOVEL MUTANT BACTERIORHODOPSIN-LIKE-CHANNELRHODOPSIN ION CHANNEL

DOCK TAG SYSTEM

Biomarkers for the early detection of breast cancer

RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE

PEPTIDE USED TO PREVENT OR TREAT SYNUCLEINOPATHY

Materials and methods for treating Friedreich's Ataxia

Immunotherapy against neuronal and brain tumors

NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Compositions and Methods for the Treatment of Synucleinopathies

PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF FIBROPROLIFERATIVE VASCULAR DISEASES

CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME

Fusion proteins comprising an engineered knottin peptide and uses thereof

PEPTIDES FOR ANGIOGENIC THERAPY

POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF

ANTI-TUMOR FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

GENE THERAPY FOR BARDET-BIEDL SYNDROME

IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH

Apparatus and method for obtaining protein-enriched fractions from breast milk

HMGN partial peptide and cancer therapy using the same

CYCLIC PEPTIDE INHIBITORS OF PSD-95 AND USES THEREOF

SYNTHETIC PROTEIN CIRCUITS DETECTING SIGNAL TRANSDUCER ACTIVITY

ARTIFICIAL PROMISCUOUS T HELPER CELL EPITOPES AS IMMUNE STIMULATORS FOR SYNTHETIC PEPTIDE IMMUNOGENS

METHODS AND COMPOSITIONS FOR PROTEIN SYNTHESIS AND SECRETION

NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF

CODON-OPTIMIZED NUCLEIC ACID ENCODING SMN1 PROTEIN

COMPOSITIONS AND METHODS FOR TREATING KCNQ4-ASSOCIATED HEARING LOSS

PH20 polypeptide variants, formulations and uses thereof

PROTEIN SECRETORY FACTOR WITH HIGH SECRETORY EFFICIENCY AND AN EXPRESSION VECTOR COMPRISING THE SAME

HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT

METHOD AND PLATFORM FOR DISRUPTING INTRACELLULAR MICROTUBULES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Ferritin Heavy Chain Subunit-Based Conjugates and Application Thereof

MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY

cDNA, mRNA, PROTEIN, AND KIT AND SYSTEM FOR EVALUATING GLIOMA PROGNOSIS

GENE AND MUTATIONS THEREOF ASSOCIATED WITH SEIZURE AND MOVEMENT DISORDERS

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES

VHH polypeptides that bind to toxin b and methods of use thereof

CHANNELED FIBERS IN SEPARATION OF BIOLOGICALLY ACTIVE NANOPARTICLES

IMMUNE INDUCER

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

WNT SIGNALING AGONIST MOLECULES

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING FIBRONECTIN TYPE III DOMAINS AND CELLS COMPRISING THE SAME

Therapeutic Potential of Peptides from the "Netrin-Like" Domain of the FRZB Protein

EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF

METHODS AND COMPOSITIONS FOR ENHANCING STABILITY AND SOLUBILITY OF SPLIT-INTEINS

SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS

FUSION PROTEINS AND METHODS OF USE THEREOF

MITOCHONDRIAL-DERIVED PEPTIDES AND ANALOGS THEREOF FOR USE AS A THERAPY FOR AGE-RELATED DISEASES INCLUDING CANCER

ANTIBACTERIAL PROTEIN CDL200 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIOIDES DIFFICILE

TUNING OF RELEASE KINETICS IN HYDROGELS

PH20 polypeptide variants, formulations and uses thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS